Therakos, Inc. Launches Lighting Up Lives Anniversary Campaign to Celebrate 25-Year Impact of Innovative Immune Modulation Therapy

ATLANTA--(BUSINESS WIRE)--Therakos, Inc., a pioneer in the development of an innovative therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives in the U.S., a year-long global initiative marking the 25-year anniversary of the introduction of ECP for the treatment of cutaneous T-cell lymphoma (CTCL), a rare form of non-Hodgkin’s lymphoma. The campaign honors the lives of CTCL patients impacted by ECP, as well as the healthcare professionals, caregivers and treatment centers that support them every step of the way. By providing CTCL patients who are unresponsive to other therapies with an alternative to pills or topical treatments, this well-tolerated option has helped many live their lives, and not be defined by their disease. Therakos encourages everyone to join the celebration at www.lightinguplives.com.